Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 2 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar pchop123 (79.56) Submitted: 2/27/2013 4:52:44 PM : Outperform Start Price: $3.81 FLML Score: +4.52

good buyin point

Featured Broker Partners


Advertisement